The High Potency API (HPAI) market is a subset of the pharmaceutical intermediates market, focusing on the production of active pharmaceutical ingredients (APIs) with high potency. These APIs are used in the manufacture of drugs and other pharmaceutical products, and are typically produced in small quantities due to their potency. HPAI production requires specialized equipment and processes, as well as stringent safety protocols, to ensure the safety of workers and the environment. HPAI production is a complex process, involving multiple steps such as synthesis, purification, and formulation. The production of HPAI is highly regulated, and manufacturers must adhere to strict quality standards to ensure the safety and efficacy of their products. Companies in the HPAI market include Lonza, Boehringer Ingelheim, Dr. Reddy's Laboratories, and Aurobindo Pharma. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
